BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 27325480)

  • 1. Reirradiation of Head and Neck Cancers With Proton Therapy: Outcomes and Analyses.
    Phan J; Sio TT; Nguyen TP; Takiar V; Gunn GB; Garden AS; Rosenthal DI; Fuller CD; Morrison WH; Beadle B; Ma D; Zafereo ME; Hutcheson KA; Kupferman ME; William WN; Frank SJ
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):30-41. PubMed ID: 27325480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
    Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reirradiation of Recurrent and Second Primary Head and Neck Cancer With Proton Therapy.
    McDonald MW; Zolali-Meybodi O; Lehnert SJ; Estabrook NC; Liu Y; Cohen-Gadol AA; Moore MG
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):808-819. PubMed ID: 27788954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-Institutional Prospective Study of Reirradiation with Proton Beam Radiotherapy for Locoregionally Recurrent Non-Small Cell Lung Cancer.
    Chao HH; Berman AT; Simone CB; Ciunci C; Gabriel P; Lin H; Both S; Langer C; Lelionis K; Rengan R; Hahn SM; Prabhu K; Fagundes M; Hartsell W; Mick R; Plastaras JP
    J Thorac Oncol; 2017 Feb; 12(2):281-292. PubMed ID: 27826034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reirradiation of head and neck cancer: Long-term disease control and toxicity.
    Bots WTC; van den Bosch S; Zwijnenburg EM; Dijkema T; van den Broek GB; Weijs WLJ; Verhoef LCG; Kaanders JHAM
    Head Neck; 2017 Jun; 39(6):1122-1130. PubMed ID: 28263446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer.
    Ling DC; Vargo JA; Ferris RL; Ohr J; Clump DA; Yau WW; Duvvuri U; Kim S; Johnson JT; Bauman JE; Branstetter BF; Heron DE
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):973-980. PubMed ID: 27302512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses.
    Takiar V; Garden AS; Ma D; Morrison WH; Edson M; Zafereo ME; Gunn GB; Fuller CD; Beadle B; Frank SJ; William WN; Kies M; El-Naggar AK; Weber R; Rosenthal DI; Phan J
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1117-31. PubMed ID: 27354127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly conformal reirradiation in patients with prior oropharyngeal radiation: Clinical efficacy and toxicity outcomes.
    Bagley AF; Garden AS; Reddy JP; Moreno AC; Frank SJ; Rosenthal DI; Morrison WH; Gunn GB; Fuller CD; Shah SJ; Ferrarotto R; Sturgis EM; Gross ND; Phan J
    Head Neck; 2020 Nov; 42(11):3326-3335. PubMed ID: 32776401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Prospective Study of Proton Beam Reirradiation for Esophageal Cancer.
    Fernandes A; Berman AT; Mick R; Both S; Lelionis K; Lukens JN; Ben-Josef E; Metz JM; Plastaras JP
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):483-487. PubMed ID: 26847847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reirradiation of thoracic cancers with intensity modulated proton therapy.
    Ho JC; Nguyen QN; Li H; Allen PK; Zhang X; Liao Z; Zhu XR; Gomez D; Lin SH; Gillin M; Komaki R; Hahn S; Chang JY
    Pract Radiat Oncol; 2018; 8(1):58-65. PubMed ID: 28867546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes after local field conformal reirradiation of patients with retropharyngeal nodal metastasis.
    Pollard C; Nguyen TP; Ng SP; Frank SJ; Garden AS; Gunn GB; Fuller CD; Beadle BM; Morrison WH; Shah SJ; Wang H; Tung S; Wang C; Ginsberg LD; Zafereo ME; Sturgis EM; Su SY; Hanna EY; Rosenthal DI; Phan J
    Head Neck; 2017 Oct; 39(10):2079-2087. PubMed ID: 28741749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of treatment outcomes following reirradiation in locoregionally recurrent head and neck cancer patients: A single institutional study.
    Kakria A; Rawat S; Bhutani R; Gupta G; Devnani B; Wahi IK; Ahlawat P
    Asia Pac J Clin Oncol; 2015 Jun; 11(2):129-34. PubMed ID: 25132076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
    Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily reirradiation for rectal cancer in patients who have received previous pelvic radiotherapy.
    Ng MK; Leong T; Heriot AG; Ngan SY
    J Med Imaging Radiat Oncol; 2013 Aug; 57(4):512-8. PubMed ID: 23870353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reirradiation of Prostate Cancer Local Failures After Previous Curative Radiation Therapy: Long-Term Outcome and Tolerance.
    Zilli T; Benz E; Dipasquale G; Rouzaud M; Miralbell R
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):318-322. PubMed ID: 27475672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
    Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies.
    Fan M; Kang JJ; Lee A; Fan D; Wang H; Kitpanit S; Fox P; Sine K; Mah D; McBride SM; Tsai CJ; Riaz N; Dunn LA; Sherman EJ; Michel L; Singh B; Ganly I; Wong RJ; Boyle JO; Cohen MA; Lee NY
    Cancer; 2020 Jan; 126(9):1905-1916. PubMed ID: 32097507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous-course reirradiation with concurrent carboplatin and paclitaxel for locally recurrent, nonmetastatic squamous cell carcinoma of the head-and-neck.
    Kharofa J; Choong N; Wang D; Firat S; Schultz C; Sadasiwan C; Wong S
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):690-5. PubMed ID: 22112556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes.
    McAvoy S; Ciura K; Wei C; Rineer J; Liao Z; Chang JY; Palmer MB; Cox JD; Komaki R; Gomez DR
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):819-27. PubMed ID: 25220718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies.
    Kramer NM; Horwitz EM; Cheng J; Ridge JA; Feigenberg SJ; Cohen RB; Nicolaou N; Sherman EJ; Babb JS; Damsker JA; Langer CJ
    Head Neck; 2005 May; 27(5):406-14. PubMed ID: 15719391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.